New research shows patients with Parkinson's disease were more willing to help others after taking their dopamine-boosting ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

In one of the largest studies of its kind, researchers found that increasing dopamine levels with L-DOPA made people slightly ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and decision-making in humans so far, providing evidence for effects of the former on the ...

Home > Press release: Dopamine increases willingness to wait ... L-DOPA, a precursor of the neurotransmitter dopamine, makes humans wait longer for rewards, as new research addresses gaps in earlier ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and decision-making in humans so far ...

New recovery school in Loudoun County, Virginia, provides academic and treatment support for students with substance abuse ...

By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 28, 2025 (HealthDay News) — Ketamine might not be effective in treating ...

The marketing boom has kept pace. Sports broadcasts are saturated with betting odds, flashy graphics and influencer ...

This approval represents another step in Sunshine Biopharma’s strategic expansion into the generic pharmaceuticals market. According to data cited by the company, global Domperidone sales are ...